Related Experiment Video
Updated: Sep 17, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Whole Slide Image vs Microscope Glass Slide Performance for the Evaluation of Programmed Death-Ligand 1 (PD-L1)
Micki Adams1, Deanna Moquin1, Siena Tabuena-Frolli1
1Agilent Technologies, Inc, Life Sciences and Diagnostics Markets Group (LDG), Companion Diagnostics (CDx) Division, Carpinteria, California.
Microscope glass slide (MGS) and whole slide image (WSI) scoring for programmed death-ligand 1 (PD-L1) expression showed high concordance. This demonstrates comparable performance between MGS and WSI for PD-L1 evaluation across 14 tumor types.
Area of Science:
- Oncology
- Pathology
- Biotechnology
Background:
- Accurate assessment of programmed death-ligand 1 (PD-L1) expression is crucial for guiding immunotherapy in cancer treatment.
- Traditional scoring relies on microscope glass slides (MGS), but digital pathology using whole slide images (WSI) offers potential advantages.
Purpose of the Study:
- To evaluate the concordance between PD-L1 expression scoring using MGS and WSI.
- To demonstrate comparable performance of MGS and WSI scoring for PD-L1 evaluation across multiple tumor types and cutoffs.
Main Methods:
- PD-L1 expression was assessed using the PD-L1 22C3 pharmDx assay on formalin-fixed, paraffin-embedded specimens for 14 tumor types.
- Qualified study readers scored PD-L1 expression using both MGS and WSI (Aperio AT2 scanner) with a washout period.
- Scoring algorithms included Tumor Proportion Score and Combined Positive Score at predefined cutoffs.
Main Results:
- Percent agreement between MGS and WSI scoring was ≥89% across all tumor types and cutoffs.
- Concordance correlation coefficient values were ≥0.80 for all tumor types and cutoffs.
- Analysis revealed high concordance with low variability and bias between MGS and WSI scoring.
Conclusions:
- Digital pathology scoring of PD-L1 expression using WSI demonstrates comparable performance to traditional MGS scoring.
- WSI offers a reliable alternative for PD-L1 evaluation, supporting its use in clinical practice and research.
- High concordance across diverse tumor types validates the robustness of WSI-based PD-L1 assessment.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018